Evidence map›Paper›PMID 38077722›Full record

ArticlePublic health action2023

Lessons for TB from the COVID-19 response: qualitative data from Brazil, India and South Africa.

H Myburgh, M Kaur, P Kaur, V Santos, C Almeida, G Hoddinott, D T Wademan, P V M Lakshmi, M Osman, S-A Meehan and 4 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Public health action, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 6 countries.

H MyburghDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
M KaurDepartment of Community Medicine & School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
P KaurDepartment of Community Medicine & School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
V SantosPrefeitura Municipal De Quissamã: Health, Rio de Janeiro, RJ.
C AlmeidaDepartment of Internal Medicine, Medical School, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
G HoddinottDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
D T WademanDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
P V M LakshmiDepartment of Community Medicine & School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
M OsmanDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
S-A MeehanDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
A C HesselingDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
A PurtyPondicherry Institute of Medical Sciences, Department of Community Medicine, Puducherry.
U B SinghAll India Institute of Medical Sciences, Department of Microbiology, New Delhi, India.
A TrajmanDepartment of Internal Medicine, Medical School, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Post Graduate Institute of Medical Education and Research · INStellenbosch University · ZAAll India Institute of Medical Sciences · INDesmond Tutu HIV Foundation · ZAInternational Institute of Social History · NLITPEnergised Group (India) · INMcGill University · CAUniversidade Federal do Rio de Janeiro · BRUniversity of Greenwich · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBrazil, India and South Africa are among the top 30 high TB burden countries globally and experienced high rates of SARS-CoV-2 infection and mortality. The COVID-19 response in each country was unprecedented and complex, informed by distinct political, economic, social and health systems contexts. While COVID-19 responses have set back TB control efforts, they also hold lessons to inform future TB programming and services.

methodsThis was a qualitative exploratory study involving interviews with TB stakeholders (

resultsPolitical will - whether national or subnational - enabled implementation of widespread prevention measures during the COVID-19 response in each country and stimulated mobile and telehealth service delivery innovations. Participants in all three countries emphasised the importance of mobilising and engaging communities in public health responses and noted limited health education and information as barriers to implementing TB control efforts at the community level.

conclusionsBuilding political will and social mobilisation must become more central to TB programming. COVID-19 has shown this is possible. A similar level of investment and collaborative effort, if not greater, as that seen during the COVID-19 pandemic is needed for TB through multi-sectoral partnerships.

Indexed as

community engagementCOVID-19political willrecoveryTB

Identifiers

PMID38077722
PMCPMC10703135
OpenAlexW4389484282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.